0.6849
price down icon0.45%   -0.0031
 
loading
Kronos Bio Inc stock is traded at $0.6849, with a volume of 310.03K. It is down -0.45% in the last 24 hours and down -22.18% over the past month. Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
See More
Previous Close:
$0.688
Open:
$0.6761
24h Volume:
310.03K
Relative Volume:
0.66
Market Cap:
$41.76M
Revenue:
-
Net Income/Loss:
$-112.67M
P/E Ratio:
-0.3512
EPS:
-1.95
Net Cash Flow:
$-79.26M
1W Performance:
+0.54%
1M Performance:
-22.18%
6M Performance:
-24.15%
1Y Performance:
-29.39%
1-Day Range:
Value
$0.6751
$0.69
1-Week Range:
Value
$0.6675
$0.70
52-Week Range:
Value
$0.65
$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name
Name
Kronos Bio Inc
Name
Phone
(650) 781-5200
Name
Address
1300 S. EL CAMINO REAL, SAN MATEO
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
KRON's Discussions on Twitter

Compare KRON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
KRON
Kronos Bio Inc
0.6849 42.98M 0 -112.67M -79.26M -1.95
Biotechnology icon
ONC
Beigene Ltd Adr
240.18 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.85 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.76 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
74.68 5.92B 0 -153.72M -103.81M -2.00

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Downgrade Piper Sandler Overweight → Neutral
Nov-14-24 Downgrade TD Cowen Buy → Hold
Sep-14-22 Initiated Berenberg Buy
Oct-20-21 Resumed Cowen Outperform
Jun-24-21 Initiated H.C. Wainwright Buy
Nov-03-20 Initiated Cowen Outperform
Nov-03-20 Initiated Goldman Buy
Nov-03-20 Initiated Jefferies Buy
Nov-03-20 Initiated Piper Sandler Overweight
View All

Kronos Bio Inc Stock (KRON) Latest News

pulisher
May 22, 2025

Shareholders Filed a Lawsuit Against Kronos Bio for Merger Disclosure Failures - TradingView

May 22, 2025
pulisher
May 22, 2025

Kronos Bio ($KRON) Misleading Merger Proxy and Insider Enrichment Case - TradingView

May 22, 2025
pulisher
May 21, 2025

Kronos Bio Shareholder Says Sale Unfairly Benefits Execs - Law360

May 21, 2025
pulisher
May 21, 2025

Kronos Bio, Board Sued by Shareholder Over Concentra Buyout Deal - Bloomberg Law News

May 21, 2025
pulisher
May 18, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AXL, KRON, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.

May 18, 2025
pulisher
May 16, 2025

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - Benzinga

May 16, 2025
pulisher
May 15, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (NasdaqXAGE), Southern States Bancshare - TradingView

May 15, 2025
pulisher
May 13, 2025

Kronos Bio discovers p300 inhibitors - BioWorld MedTech

May 13, 2025
pulisher
May 10, 2025

Weekly CEO Buys Highlight - GuruFocus

May 10, 2025
pulisher
May 05, 2025

Concentra Biosciences Agrees to Acquire Kronos Bio - Contract Pharma

May 05, 2025
pulisher
May 04, 2025

KRONOS BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kronos Bio, Inc.KRON - Business Wire

May 04, 2025
pulisher
May 02, 2025

KRON Shares Experience Decline in Value - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Kronos shares slump on Concentra takeover news - The Pharma Letter

May 02, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) to Merge with Concentra Biosciences in $0.57 P - GuruFocus

May 01, 2025
pulisher
May 01, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc.KRON - PR Newswire

May 01, 2025
pulisher
May 01, 2025

Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investorSan Francisco Business Times - The Business Journals

May 01, 2025
pulisher
May 01, 2025

Now Is The Time To Build A Position In Kronos Bio Inc (NASDAQ:KRON) - Marketing Sentinel

May 01, 2025
pulisher
May 01, 2025

KRON’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Today’s watch list includes Kronos Bio Inc (NASDAQ:KRON) stock - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio stock hits 52-week low at $0.68 amid market challenges - Investing.com India

May 01, 2025
pulisher
May 01, 2025

After hunt for alternatives, Kronos Bio selects Tang Capital’s Concentra for a deal - Endpoints News

May 01, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) to be Acquired by Concentra Biosciences in Strategic Merger | KRON Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - The Joplin Globe

May 01, 2025
pulisher
May 01, 2025

KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders - The Joplin Globe

May 01, 2025
pulisher
May 01, 2025

Concentra To Acquire Kronos Bio - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Kronos Bio agrees to Concentra Biosciences acquisition - Investing.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by - GlobeNewswire

May 01, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) Projected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Has $1.11 Million Position in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Apr 30, 2025
pulisher
Apr 11, 2025

Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia

Apr 11, 2025
pulisher
Apr 10, 2025

Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Kronos Bio Announces Lease Termination Agreement - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times

Apr 10, 2025
pulisher
Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025
pulisher
Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 25, 2025
pulisher
Mar 20, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance

Mar 20, 2025
pulisher
Mar 18, 2025

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio Inc (KRON) Q4 2024 Earnings: EPS Misses at -$0.43, Re - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

China Revives Its Carbon Credit Market: Price Swings & Future Outlook - The Globe and Mail

Mar 18, 2025
pulisher
Mar 18, 2025

Navigating the U.S. Planting Season with Enhanced Risk Management - The Globe and Mail

Mar 18, 2025

Kronos Bio Inc Stock (KRON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.89
price down icon 0.52%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Cap:     |  Volume (24h):